We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
BioLife Solutions
BLFS
$1.88B
| $2.94M | ﹤0.01% |
103,975
+9,396
| +10% | +$220K |
|
1727
STAAR Surgical
STAA
$1.03B
| $2.94M | ﹤0.01% |
102,305
-26,952
| -21% | -$749K |
|
1728
Xencor
XNCR
$1.77B
| $2.92M | ﹤0.01% |
181,617
+11,156
| +7% | +$139K |
|
1729
Alpha and Omega Semiconductor
AOSL
$845M
| $2.92M | ﹤0.01% |
61,676
-10,369
| -14% | -$416K |
|
1730
Sumitomo Mitsui Financial
SMFG
$169B
| $2.91M | ﹤0.01% |
123,552
+9,563
| +8% | +$212K |
|
1731
Vir Biotechnology
VIR
$1.8B
| $2.91M | ﹤0.01% |
285,154
+52,604
| +23% | +$500K |
|
1732
Enliven Therapeutics
ELVN
$3.28B
| $2.9M | ﹤0.01% |
57,241
+7,053
| +14% | +$299K |
|
1733
Upbound Group
UPBD
$938M
| $2.9M | ﹤0.01% |
136,873
-11,510
| -8% | -$215K |
|
1734
XPEL
XPEL
$1.2B
| $2.9M | ﹤0.01% |
58,446
-7,427
| -11% | -$338K |
|
1735
Flywire
FLYW
$2.12B
| $2.89M | ﹤0.01% |
164,759
+6,594
| +4% | +$97.4K |
|
1736
Syndax Pharmaceuticals
SNDX
$1.63B
| $2.89M | ﹤0.01% |
132,358
+17,596
| +15% | +$366K |
|
1737
United Parks & Resorts
PRKS
$1.51B
| $2.89M | ﹤0.01% |
60,553
-19,622
| -24% | -$761K |
|
|
KRMN
1738
Karman Holdings
KRMN
$4.73B
| $2.87M | ﹤0.01% |
57,579
+4,155
| +8% | +$269K |
|
1739
Inspire Medical Systems
INSP
$2.04B
| $2.86M | ﹤0.01% |
64,202
-3,705
| -5% | -$176K |
|
1740
Federal Agricultural Mortgage
AGM
$2.32B
| $2.85M | ﹤0.01% |
14,322
+1,071
| +8% | +$188K |
|
1741
Establishment Labs
ESTA
$1.97B
| $2.84M | ﹤0.01% |
+33,118
| New | +$2.38M |
|
1742
NCR Voyix
VYX
$976M
| $2.84M | ﹤0.01% |
347,375
-84,954
| -20% | -$598K |
|
1743
Spectrum Brands
SPB
$1.95B
| $2.81M | ﹤0.01% |
32,813
+2,059
| +7% | +$167K |
|
1744
Immunome
IMNM
$2.43B
| $2.81M | ﹤0.01% |
132,479
+11,579
| +10% | +$248K |
|
1745
Freshworks
FRSH
$3.27B
| $2.8M | ﹤0.01% |
277,072
+24,082
| +10% | +$214K |
|
1746
Simply Good Foods
SMPL
$849M
| $2.8M | ﹤0.01% |
210,862
-34,869
| -14% | -$430K |
|
1747
BioCryst Pharmaceuticals
BCRX
$2.2B
| $2.8M | ﹤0.01% |
279,839
+13,702
| +5% | +$124K |
|
1748
Bristow Group
VTOL
$1.26B
| $2.8M | ﹤0.01% |
67,719
-11,679
| -15% | -$523K |
|
1749
Deluxe
DLX
$1.12B
| $2.79M | ﹤0.01% |
116,880
-12,299
| -10% | -$320K |
|
|
NAVN
1750
Navan Inc
NAVN
$5.05B
| $2.79M | ﹤0.01% |
122,011
+77,598
| +175% | +$1.42M |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.